Expression of tumor necrosis factor α and its correlation with severity of oral submucous fibrosis: a case-control study

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Jun;117(6):704-8. doi: 10.1016/j.oooo.2014.02.030. Epub 2014 Mar 12.

Abstract

Objective: The objective of this case-control study was to evaluate the plasma tumor necrosis factor α (TNF-α) levels in patients with oral submucous fibrosis and to determine the relation of plasma TNF-α levels with the severity of oral submucous fibrosis.

Study design: Blood samples were collected from 25 patients who were diagnosed with oral submucous fibrosis and from 25 age- and sex-matched control participants. The plasma was isolated by centrifugation of blood samples. The levels of plasma TNF-α were estimated using enzyme-linked immunosorbent assay.

Results: A total of 19 out of 25 patients had detectable plasma TNF-α levels ranging from 0.1 to 106.4 pg/mL (mean, 23.46 pg/mL), whereas only 12 out of 25 control participants had detectable plasma TNF-α levels ranging from 0.1 to 33.3 pg/mL (mean, 6.93 pg/mL). The difference between the TNF-α levels of patients and controls was statistically significant (P = .015) according to the Mann-Whitney test.

Conclusions: Patients with oral submucous fibrosis had significantly increased TNF-α levels compared with controls.

MeSH terms

  • Areca
  • Case-Control Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Male
  • Oral Submucous Fibrosis / blood*
  • Risk Factors
  • Severity of Illness Index
  • Tobacco, Smokeless
  • Tumor Necrosis Factor-alpha / blood*

Substances

  • Tumor Necrosis Factor-alpha